Literature DB >> 17449979

Medical considerations of long-term survival of Werdnig-Hoffmann disease.

John R Bach1.   

Abstract

OBJECTIVES: To report intercurrent nonrespiratory complications of unprecedented survival for Werdnig-Hoffman disease (spinal muscular atrophy type 1 [SMA 1]).
DESIGN: A retrospective chart review and caregiver questionnaire for 103 consecutively referred SMA 1 patients for whom death was prevented during infancy.
RESULTS: Overall, 15 of 63 (23.8%) respondents had severe, symptomatic bradycardias. Thirteen of 25 males had bilateral cryptorchidism, and two were unilateral. Ten of 42 (24%) respondents had recurrent oral candidiasis, and eight (19.0%) had recurrent nonoral candidiasis. All patients had hip dislocation/subluxation. They had collapsing spines and scoliosis by 1 yr of age. Ninety-six had indwelling gastrostomy/nasogastric tubes before 24 mos of age. Twenty-six underwent fundoplication to decrease reflux. Fifty-seven were on modified elemental diets with reported benefits. About one half had early pubarche. Three patients had episodes of acute pancreatitis. One untreated patient died of candidal endocarditis at 4 mos of age, and a second child had mitral valve candidiasis on autopsy.
CONCLUSION: Prolonged survival of SMA 1 results in a high incidence of concomitant medical conditions that need to be addressed.

Entities:  

Mesh:

Year:  2007        PMID: 17449979     DOI: 10.1097/PHM.0b013e31804b1d66

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  29 in total

1.  Genetic counseling for the orthodox jewish couple undergoing preimplantation genetic diagnosis.

Authors:  B E David; G A Weitzman; C Hervé; M Fellous
Journal:  J Genet Couns       Date:  2012-04-25       Impact factor: 2.537

2.  Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models.

Authors:  Melissa Osborne; Daniel Gomez; Zhihua Feng; Corissa McEwen; Jose Beltran; Kim Cirillo; Bassem El-Khodor; Ming-Yi Lin; Yun Li; Wendy M Knowlton; David D McKemy; Laurent Bogdanik; Katherine Butts-Dehm; Kimberly Martens; Crystal Davis; Rosalinda Doty; Keegan Wardwell; Afshin Ghavami; Dione Kobayashi; Chien-Ping Ko; Sylvie Ramboz; Cathleen Lutz
Journal:  Hum Mol Genet       Date:  2012-07-16       Impact factor: 6.150

3.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

4.  SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice.

Authors:  Sara E Gombash; Christopher J Cowley; Julie A Fitzgerald; Chitra C Iyer; David Fried; Vicki L McGovern; Kent C Williams; Arthur H M Burghes; Fedias L Christofi; Brian D Gulbransen; Kevin D Foust
Journal:  Hum Mol Genet       Date:  2015-04-09       Impact factor: 6.150

5.  Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II/III spinal muscular atrophy.

Authors:  Laurent P Bogdanik; Melissa A Osborne; Crystal Davis; Whitney P Martin; Andrew Austin; Frank Rigo; C Frank Bennett; Cathleen M Lutz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

6.  A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse.

Authors:  Paul N Porensky; Chalermchai Mitrpant; Vicki L McGovern; Adam K Bevan; Kevin D Foust; Brain K Kaspar; Stephen D Wilton; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

7.  Therapeutic developments in spinal muscular atrophy.

Authors:  Douglas M Sproule; Petra Kaufmann
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 8.  Antisense oligonucleotides for the treatment of spinal muscular atrophy.

Authors:  Paul N Porensky; Arthur H M Burghes
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

9.  Vascular perfusion abnormalities in infants with spinal muscular atrophy.

Authors:  Alexandra prufer de Queiroz Campos Araujo; Mario Araujo; Kathryn J Swoboda
Journal:  J Pediatr       Date:  2009-08       Impact factor: 4.406

Review 10.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.